Your healthcare provider should assess personal suitability, including thyroid cancer history, personal or family medullary thyroid cancer, pancreatitis history, and current medications
A recent study from the University of Copenhagen highlights new concerns about GLP-1 medications, including Ozempic, Wegovy, and Mounjaro, focusing on potential bone density loss
These factors can encourage weight gain
However, this method is not suitable for all, due the highly invasive nature and associated risks for patients, particularly those with cardiovascular problems
80 LynchA
Pharmaceutical R&D returns for the world's top 20 pharma companies have improved for a third consecutive year to 7%, thanks almost entirely to a handful of high-forecast assets such as glucagon-like peptide receptor agonists, or GLP-1s